Have a personal or library account? Click to login
Relevant nursing measures for the adverse reactions associated with chimeric antigen receptor T cells (CAR-T) immunotherapy: a systematic review of case reports† Cover

Relevant nursing measures for the adverse reactions associated with chimeric antigen receptor T cells (CAR-T) immunotherapy: a systematic review of case reports†

Frontiers of Nursing
Volume 6 (2019): Issue 2 (June 2019)
By: Xu Zhang,  Di Sun and  Gui-Chun Jiang  
Open Access
|Jul 2019

References

  1. Ramos CA, Dotti G. Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy. Expert Opin Biol Ther. 2011;11:855-873.10.1517/14712598.2011.57347621463133
    Open DOISearch in Google ScholarBack to article
  2. Firor AE, Jares A, Ma Y. From humble beginnings to success in the clinic: chimeric antigen receptor-modified T-cells and implications for immunotherapy. Exp Biol Med (Maywood). 2015;240:1087-1098.10.1177/153537021558493625956686
    Open DOISearch in Google ScholarBack to article
  3. Porter DL, Levine BL, Kalos M, Bagg A, June CH. Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia. N Engl J Med. 2011;365:725-733.2183094010.1056/NEJMoa1103849
    Open DOISearch in Google ScholarBack to article
  4. Zhu Y, Tan Y, Ou R, et al. Anti-cd19 chimeric antigen receptor-modified T cells for b-cell malignancies: a systematic review of efficacy and safety in clinical trials. Eur J Haematol. 2016;96:389-396.2611535810.1111/ejh.12602
    Open DOISearch in Google ScholarBack to article
  5. Maude SL, Frey N, Shaw PA, et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med. 2014;371:1507-1517.10.1056/NEJMoa140722225317870
    Open DOISearch in Google ScholarBack to article
  6. Lee DW, Gardner R, Porter DL, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124:188-195.10.1182/blood-2014-05-55272924876563
    Open DOISearch in Google ScholarBack to article
  7. Grupp SA, Kalos M, Barrett D, et al. Chimeric antigen receptor–modified T cells for acute lymphoid leukemia. N Engl J Med. 2013;368:1509-1518.2352795810.1056/NEJMoa1215134
    Open DOISearch in Google ScholarBack to article
  8. Maus MV, Grupp SA, Porter DL, June CH. Antibody-modified T cells: cars take the front seat for hematologic malignancies. Blood. 2014;123:2625-2635.2457850410.1182/blood-2013-11-492231
    Open DOISearch in Google ScholarBack to article
  9. Kochenderfer JN, Dudley ME, Carpenter RO, et al. Donor-derived cd19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. Blood. 2013;122:4129-4139.10.1182/blood-2013-08-51941324055823
    Open DOISearch in Google ScholarBack to article
  10. Ke XY. Application progress of chimeric antigen receptor - T cell immunotherapy in hematological malignancies. Chin General Med. 2016;19:1361-1366 (in Chinese).
    Search in Google ScholarBack to article
  11. Moga C, Guo B, Schopflocher D. Development of a Quality Appraisal Tool for Case Series Studies Using a Modified Delphi Technique. Vol. 25. Edmonton AB: Institute of Health Economics; 2012:1262-1268.
    Search in Google ScholarBack to article
  12. Yu LL. Nursing care of 7 children with advanced malignant solid tumor treated with CAR-T cell combined with chemotherapy. Tianjin Nurs. 2017;25:528-529 (in Chinese).
    Search in Google ScholarBack to article
  13. Zhang P, Dai JX, Zhou L. Nursing care of patients with relapsed and refractory hematological malignancies undergoing CART cell therapy. Med Inf. 2016;29:226-227 (in Chinese).
    Search in Google ScholarBack to article
  14. Chen XL, Feng YM, Zeng YJ, et al. Exploration of integrated nursing care on CAR-T cell immunotherapy for refractory acute lymphocytic leukemia. Chin J Blood Transfusion. 2016;29:1104-1107 (in Chinese).
    Search in Google ScholarBack to article
  15. Feng N, Du X, Zhang C, Hao J, Zeng L. Nursing care of patients with recurrent refractory acute lymphoblastic leukemia treated with chimeric antigen receptor. Chongqing Med. 2016;45:140-141 (in Chinese).
    Search in Google ScholarBack to article
  16. Li LN, Wan Y. Nursing care of patients with B cell malignant tumor treated with chimeric antigen receptor modified T cell immunotherapy. Chin J Nurs. 2017;52:297-299 (in Chinese).
    Search in Google ScholarBack to article
  17. Ding YG, Zhao W, Wu XY, Ma XL. Nursing experience of children with neuroblastoma developing adverse reaction after retransfusion of chimeric antigen receptor-transduced T-cells. Chin J Nurs. 2017;52:307-310 (in Chinese).
    Search in Google ScholarBack to article
  18. Turtle CJ. Chimeric antigen receptor modified T cell therapy for B cell malignancies. Int J Hematol. 2014;99:132-140.10.1007/s12185-013-1490-x24338745
    Open DOISearch in Google ScholarBack to article
  19. Yamauchi K, Yang M, Hayashi K, et al. Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy. Cancer Res. 2008;68:516-520.1819954710.1158/0008-5472.CAN-07-3063
    Open DOISearch in Google ScholarBack to article
  20. Pan J, Yang JF, Deng BP, et al. High efficacy and safety of low-dose cd19-directed CAR-T cell therapy in 51 refractory or relapsed b acute lymphoblastic leukemia patients. Leukemia. 2017;31:2587-2593.10.1038/leu.2017.14528490811
    Open DOISearch in Google ScholarBack to article
  21. Gardner RA, Finney O, Annesley C, et al. Intent to treat leukemia remission by cd19car T cells of defined formulation and dose in children and young adults. Blood. 2017;129:3322-3331.
    Search in Google ScholarBack to article
  22. Mol MM, Boeter GW, Verharen L, Kompanje EJ, Bakker J, Nijkamp MD. Patient- and family-centered care in the intensive care unit, a challenge in the daily practice of healthcare professionals. J Clin Nurs. 2016;26:3212-3223.
    Search in Google ScholarBack to article
  23. Thuy NL, Clemenceau AL, Lebaron VT. Challenges encountered by Vietnamese nurses when caring for patients with cancer. Oncol Nurs Forum. 2017;44:147-151.28222082
    Search in Google ScholarBack to article
  24. Morsch CM, Gonçalves LF, Barros E. Health-related quality of life among haemodialysis patients - relationship with clinical indicators, morbidity and mortality. J Clin Nurs. 2006;15:498-504.10.1111/j.1365-2702.2006.01349.x16553764
    Open DOISearch in Google ScholarBack to article
DOI: https://doi.org/10.2478/FON-2019-0014 | Journal eISSN: 2544-8994 | Journal ISSN: 2097-5368
Journal RSS Feed
Language: English
Page range: 87 - 95
Submitted on: Oct 3, 2018
|
Accepted on: Dec 22, 2018
|
Published on: Jul 10, 2019
Published by: Shanxi Medical Periodical Press
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
chimeric antigen receptor T cells,
immunotherapy,
neoplasms,
nursing
Related subjects:
Medicine,
Assistive professions, nursing

© 2019 Xu Zhang, Di Sun, Gui-Chun Jiang, published by Shanxi Medical Periodical Press
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 6 (2019): Issue 2 (June 2019)Next article